Reference
- Parsons JM. Management of toxic epidermal necrolysis. Cutis 1985; (Oct):305–10
- Avakian R, Flowers FP, Araujo OE, et al. Toxic epidermal necrolysis: a review. J Am Acad Dermatol 1991; 25: 69–79
- Schwartz RA. Toxic epidermal necrolysis. Cutis 1997; 59:123–8
- Roujeau J, Chosidow O, Saiag P, et al. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990; 23: 1039–58
- Schöpf E, Stühmer A, Rzany P, et al. Toxic epidermal necrolysis and StevensJohnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839–42
- Chan HL. Observations on drug-induced toxic epidermal necrolysis in Singapore. J Am Acad Dermatol 1984; 10:973–8
- Fritsch PO, Ruiz-Maldonado R. Stevens-Johnson syndrome: toxic epidermal necrolysis. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's dermatology in general medicine. 5th ed, vol 1. New York: McGraw-Hill Health Professions Division, 1999: 644–54
- Tong P, Mutasim DF. Toxic epidermal necrolysis in the elderly. J Geriatr Dermatol 1996; 4(2):63–70
- Revuz J, Penso D, Roujeau J, et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987; 123:1160–5